SCHEMBL7412499

SCHEMBL7412499

COC(=O)CCC(=O)c1ccc2c(c1)CNC(=O)N2C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
HPGD P15428 3/20 0.37
SMYD3 Q9H7B4 1/20 0.37
NOTUM Q6P988 1/20 0.36
KAT2B Q92831 3/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CASP3 P42574 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 1/20 0.36
HTT P42858 2/20 0.35
ALDH1A1 P00352 5/20 0.35
HSD17B10 Q99714 3/20 0.35
LMNA P02545 1/20 0.35
CTNNB1 P35222 2/20 0.35
WNT3A P56704 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
KDM4E B2RXH2 2/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23535779 0.81 CASP3 (0.54) MAPTHPGDKMT2ACASP3SMN1; SMN2
SCHEMBL30040559 0.81 CASP3 (0.54) MAPTHPGDKMT2ACASP3SMN1; SMN2
SCHEMBL7412460 0.80 MAPT (0.35) MAPTHPGDSMYD3KAT2BCASP3
SCHEMBL30040376 0.77 LMNA (0.49) MAPTHPGDSMYD3POLBALDH1A1
SCHEMBL23535782 0.77 LMNA (0.49) MAPTHPGDSMYD3POLBALDH1A1
SCHEMBL10414690 0.75 BRD4 (0.50)
SCHEMBL7488353 0.73 POLB (0.70) MAPTKMT2AMEN1SMN1; SMN2POLB
SCHEMBL7416223 0.72 TNF (0.43) MAPTHPGDKMT2AMEN1CASP3
SCHEMBL7343831 0.71 USP30 (0.48) KMT2AMEN1SMN1; SMN2POLBHTT
SCHEMBL7489460 0.70 MEN1 (0.44) HPGDKMT2AMEN1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4906630-A Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds RORER PHARMACEUTICAL CORPORATION (US) 1990-03-06 US disclosed
US-4868300-A INOTROPIC AGENTS, CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1989-09-19 US disclosed
US-4785101-A CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1988-11-15 US disclosed
EP-0247177-A4 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES. RORER INTERNAT OVERSEAS INC (US) 1988-04-06 EP disclosed
US-4725686-A CONGESTIVE HEART FAILURE WILLIAM H. RORER, INC. (US) 1988-02-16 US disclosed
EP-0247177-A1 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1987-12-02 EP disclosed
WO-1987003201-A1 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1987-06-04 WO disclosed